secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oric Pharmaceuticals, Inc. (ORIC)
CIK:        0001796280
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001193125-24-161593
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ORIC shareholders re-elect directors; ratify KPMG as auditor for FY2024
-----------------------------------------------------------------------

- Class I directors Richard Heyman (36.6M for, 11.9M withheld) and Lori Kunkel (48.0M for, 0.5M withheld) re-elected.
- KPMG ratification passed: 55.6M for, 6,150 against, 338,222 abstain, no broker non-votes.
- Meeting had 55.98M shares represented (83.02% of outstanding); record date April 17, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796280/000119312524161593/0001193125-24-161593-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796280/000119312524161593/d765804d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-161593

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer